Latest Aarti Pharma Labs stock price

Aarti Pharma Labs P/E Ratio

AARTIPHARM • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
30.45
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 30.45
Current Price ₹705.75
EPS (TTM) ₹30.06
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 20.49
Historical Range 13.43 - 29.66
Percentile 100.0%

Sector Context

Sector Average 48.22
Sector Median 27.3
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹23.58
Sept 2025 ₹3.08
Mar 2025 ₹9.75

Key P/E Ratio Insights for Aarti Pharma Labs

  • Stock appears overvalued with PE of 30.45, suggesting caution for new investments
  • Current PE is 48.6% above historical average
  • Trading at discount to sector average PE of 48.22

View the AARTIPHARM equity price for detailed stock performance.

P/E Ratio Historical Trend for Aarti Pharma Labs

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 29.66 23.58 ₹699.35 NSE High
2024 18.37 27.51 ₹505.35 NSE Moderate
2023 13.43 21.47 ₹288.25 NSE Low

Sector P/E Ratio Comparison

Comparing Aarti Pharma Labs with other companies in Healthcare sector
Sector Average
48.22
Sector Median
27.3
Lowest P/E
1.1
Highest P/E
754.17
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.1 ₹38 Low
Murae Organisor MURAE 3.14 ₹47 Low
Ind Swift Laboratories INDSWFTLAB 4.87 ₹1,186 Low
Amwill Health Care AMWILL 6.5 ₹67 Low
Medicamen Organics MEDIORG 6.94 ₹27 Low
JFL Life Sciences JFLLIFE 7.53 ₹36 Low
Galaxy Medicare GML 7.66 ₹26 Low
Unichem Laboratories UNICHEMLAB 8.42 ₹2,437 Low
Zenith Drugs ZENITHDRUG 9.03 ₹85 Low
Brooks Laboratories BROOKS 9.44 ₹198 Low